First Commonwealth Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
First Commonwealth Financial's VRTX Position: Q3 2026 in Review
First Commonwealth Financial increased its Vertex Pharmaceuticals (VRTX) stake by 0.09% in Q3 2026, buying an estimated $512 and bringing the position to 1,136 shares worth $594K. The position accounts for 0.08% of the portfolio, ranked #168.
First Commonwealth Financial first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- First Commonwealth Financial held 1,136 shares of Vertex Pharmaceuticals worth $594K as of Q3 2026.
- First Commonwealth Financial bought 1 Vertex Pharmaceuticals share in Q3 2026, an estimated $512.
- Vertex Pharmaceuticals made up 0.08% of First Commonwealth Financial's portfolio in Q3 2026, its #168 holding.
- First Commonwealth Financial first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on First Commonwealth Financial's 13F filing for Q3 2026, filed 13 Nov 2026.